BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33529147)

  • 1. From genotype to phenotype: adaptations of
    Camus L; Vandenesch F; Moreau K
    Microb Genom; 2021 Mar; 7(3):. PubMed ID: 33529147
    [No Abstract]   [Full Text] [Related]  

  • 2. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
    Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
    Oliver A; Cantón R; Campo P; Baquero F; Blázquez J
    Science; 2000 May; 288(5469):1251-4. PubMed ID: 10818002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts.
    Rau MH; Hansen SK; Johansen HK; Thomsen LE; Workman CT; Nielsen KF; Jelsbak L; Høiby N; Yang L; Molin S
    Environ Microbiol; 2010 Jun; 12(6):1643-58. PubMed ID: 20406284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis.
    Armbruster CR; Marshall CW; Garber AI; Melvin JA; Zemke AC; Moore J; Zamora PF; Li K; Fritz IL; Manko CD; Weaver ML; Gaston JR; Morris A; Methé B; DePas WH; Lee SE; Cooper VS; Bomberger JM
    Cell Rep; 2021 Oct; 37(3):109829. PubMed ID: 34686349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
    Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
    BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.
    Mayer-Hamblett N; Ramsey BW; Kulasekara HD; Wolter DJ; Houston LS; Pope CE; Kulasekara BR; Armbruster CR; Burns JL; Retsch-Bogart G; Rosenfeld M; Gibson RL; Miller SI; Khan U; Hoffman LR
    Clin Infect Dis; 2014 Sep; 59(5):624-31. PubMed ID: 24863401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.
    Ruhluel D; Fisher L; Barton TE; Leighton H; Kumar S; Amores Morillo P; O'Brien S; Fothergill JL; Neill DR
    ISME J; 2024 Jan; 18(1):. PubMed ID: 38647527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.
    Nguyen D; Singh PK
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8305-6. PubMed ID: 16717189
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
    Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
    Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
    PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.
    Rossi E; La Rosa R; Bartell JA; Marvig RL; Haagensen JAJ; Sommer LM; Molin S; Johansen HK
    Nat Rev Microbiol; 2021 May; 19(5):331-342. PubMed ID: 33214718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
    Smith EE; Buckley DG; Wu Z; Saenphimmachak C; Hoffman LR; D'Argenio DA; Miller SI; Ramsey BW; Speert DP; Moskowitz SM; Burns JL; Kaul R; Olson MV
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8487-92. PubMed ID: 16687478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.